EVALUASI PENGGUNAAN STRONGER NEO MINOPHAGEN C (SNMC) INJEKSI PADA GANGGUAN FUNGSI HATI DI BEBERAPA RUMAH SAKIT DI YOGYAKARTA

• Main Authors: , ISMI NOER FARIDAH, , Dr. dr. Rina Handayani, M.Kes
• Format: Theses and Dissertations NonPeerReviewed
• Published: [Yogyakarta] : Universitas Gadjah Mada 2013
• Subjects: ETD
• Online Access: https://repository.ugm.ac.id/123204/; http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=63315
• Institution: Universitas Gadjah Mada

The use of Stronger Neo Minophagen C (SNMC) was studied in several hospitals in Yogyakarta. SNMC is an injection containing the active ingredient of glychyrrhizin which is derived from an herb and has long been used to treat liver function failure. This study is to determine the indications for SNMC and its effects to the reduction of SGOT and SGPT. This research was an observational study using a retrospective method on medical records from hospital A, B, and C in Yogyakarta between the period of January 1 to December 31, 2012. The subjects were all in-patients with the inclusion criteria of receiving SNMC, SGOT > 40 IU/L, SGPT > 40 IU/L, diagnosed with liver diseases (hepatitis A, B and C, liver cancer, cholestasis, cholelitiasis, cholesistitis, choledocholithiasis, jaundice, fatty liver, and liver abscess). A total of 230 subjects were enrolled in this study, 141 cases of liver disease and 89 cases of other diseases. From the 141 subjects, there were only 50 that fulfilled the inclusion criteria. Of the 50 patients, 12 were prescribed with single SNMC and the rest received SNMC with other medications. The results showed that single SNMC was able to decrease SGOT and SGPT by 18.05 to 93.62% and 9.31 to 77.55% respectively